| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 6 |
| 1 | CISPLATIN | 6 |
| 2 | PACLITAXEL | 6 |
| 3 | RIBOCICLIB | 6 |
| 4 | CAPECITABINE | 5 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 5 |
| 6 | TEMOZOLOMIDE | 5 |
| 7 | DOCETAXEL | 4 |
| 8 | DOCETAXEL ANHYDROUS | 4 |
| 9 | FULVESTRANT | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VINORELBINE | 4 | 0.0006 |
| 1 | FRUQUINTINIB | 1 | 0.0003 |
| 2 | AVELUMAB | 1 | 0.0002 |
| 3 | TEMOZOLOMIDE | 5 | 0.0002 |
| 4 | CYPROHEPTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 5 | RIBOCICLIB | 6 | 0.0002 |
| 6 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 2 | 0.0002 |
| 7 | ELACESTRANT | 1 | 0.0001 |
| 8 | ENFORTUMAB VEDOTIN | 1 | 0.0001 |
| 9 | NINTEDANIB | 4 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 5 | 0.0001 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 4 | Radioligand Therapeutic Agent [EPC] | 1 | 0.0001 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 6 | Aromatase Inhibitor [EPC] | 5 | 0.0000 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 3 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |